BELITE BIO INC - ADR (BLTE) Stock Income Statement
USA - NASDAQ:BLTE - US07782B1044 - ADR
113.57 USD
+0.38 (+0.34%)
112.4 USD
-1.17 (-1.03%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 54.74M | 40.00M | 32.00M | 12.82M | 9.80M | |||
| Research and Development | null | null | 24.84M | 8.87M | 7.42M | |||
| Selling, General, and Administrative Expenses | 19.77M | 10.00M | 6.82M | 3.95M | 2.38M | |||
| Operating Income | -54.74M | -40.00M | -32.00M | -12.82M | -9.80M | |||
| Interest Income/Expense | null | null | 45.00K | 170.00K | 130.00K | |||
| Other Income/Expense | 4.94M | 4.00M | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -48.68M | -36.00M | -32.00M | -12.65M | -9.67M | |||
| Income Tax | 0 | 10.00K | 10.00K | 0 | 0 | |||
| Net Income | -48.68M | -36.00M | -32.00M | -12.65M | -9.67M | |||
| EBITDA | null | -39.84M | -31.86M | -12.76M | -9.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.4565360694735032 | -1.116047118168009 | -1.1255051445931616 | -0.595855664784615 | -0.3783210570061048 | |||
| Non GAAP EPS | -1.55 | -1.1800000000000002 | -1.24 | null | null | |||
| Statistics | ||||||||
All data in USD